1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U; Standardisation Sub-committee of the International Continence Society, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.
2. Andersson K-E, Cardozo L, Cruz F, Lee K-S, Sahai A, Wein AJ. Pharmacological treatment of urinary incontinence. In: Abrams P, Cardozo L, Wagg A, Wein AJ, editors. Incontinence. 6th ed. Bristol: ICI-ICS. International Continence Society; 2017. pp. 805–958.
3. Andersson KE. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev. 1993;45(3):253–308.
4. Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int. 2007;100(5):987–1006.
5. Wein AJ, Levin RM, Barrett DM. Voiding function: relevant anatomy, physiology, and pharmacology. In: Duckett JW, Howards ST, Grayhack JT, Gillenwater JY, editors. Adult and pediatric urology. St. Louis: Mosby; 1991. p. 933–99.